A day AGI rjs shares Joe’s post on filing of IND. Joe

New Post Public Reply Private Reply Replies (0) Message Board
tc2000chartreader OrlandoJohn #18824
387
A day AGI rjs shares Joe’s post on filing of IND.

Joe comment

In my opinion long term sustained memory like our 10 year breast cancer vaccine data that was just released is the only way, and none of the other pathways like mRNA have that or significant positive with big benefit data, unless I missed it, so, a lotta work ahead!

Digi comment

There is no long term sustained protection from the coronavirus. Crap, make a cold vaccine and maybe we could believe you. Reality is Joe, it can't be done due to the mutations that take place in a short amount of time. You really want liability or did you get Nu Generex into the "Not being able to be prosecuted thing". Reality Joe.

Joe comment

Chuck Merchant that is a ridiculous statement, get facts Chuck, a subunit pathway works with epitopes, epitopes change minutely from one strain to another, example, SARS Corona 2002 is a 80 percent match from SARS to COVID 19 so to enlighten you a vaccine made for SARS with subunit antibody (Humeral) and Cellular cd4 and 8 protection would work fine with protection today, its the ones doing full spike protein that have the problems with your ridiculous uninformed comment. Comments like this are not smart, irresponsible and for sure disgustingly stupid.

Rjs comment

Chuck Merchant hey bud, the long term memory Joe referred to was proven in the Phase II breast cancer vaccine study cs the Phase I prostate vaccine study. That’s remarkable and confirms optimism for the Ii-Key CD 4, CD 8 whole vaccine approach. Such a peptide vaccine can later be specially designed for future mutations. Testing for safety, immunological response and efficacy is key though for the NuGenerex Covid vaccine. Joe can correct any of that if I’m wrong.

Digi comment

Honest question Joe. Would you take the first vaccine that Nu Generex produces?


BTW Joe, you do know that the SARS vaccine that was given to the Chinese folks produced about a 90% fatality rate when this second wave came around. It's fact if you check it. Point is Joe, it seems like there is no vaccine that can be made to protect folks. If I am wrong, then please provide me with FACTS to show that I am wrong. Fair enough?

Joe comment

Chuck Merchant I would never take a rna, dna and especially a mRNA vaccine if it’s anything less then 100 percent which they will not be that I guarantee, and if not 100 percent he’ll no, because the off targets will kill me, and if I get it again with that vaccine the off targets will kill me like cytokine storm and any of the other 20-30 off target auto immune events that could occur, but first and foremost you would have to show me any data that these pathways have any data prior that is significant positive and gives benefit, but there is none because after all the failures they finally figured it out for Covid and that’s just bullshit.


And yes I would take the first vaccine Generex produces because we never had off targets and we are the only one unless I’m wrong and missed something that has significant positive benefit data from something else, again I could be wrong but if I am someone needs to prove it to me.

And to date no ones proved nothing. Period! End of story!

Chuck Merchant have no idea what vaccine or pathway your talking about, I do know your warp speed leader from GSK killed more people then anyone in England on his GSK vaccines and ooops I forgot all those pediatrics. And I’m sure if o viral vector or use of all spike protein, non dehumanized and live virus particles it killed more then you know.

You should really stay away from science Chuck and stick to computers, oops i forgot that great philanthropist Bill Gates who couldn’t solve his viruses in his own product at Microsoft and has made 100 times more then he pretended to give away will solve this problem, hahahahaha!

Digicomment

Covid has a 3-6 month memory in our systems. Already proven. Joe just wants the price to spike. And BTW, mRNA is a disaster. It can change systematic DNA to what the mRNA wants it to do. Do some checking on it RJ.

Joe comment

Chuck Merchant says who show me the data as the fda would say

Chuck Merchant antibodies disappear in 30-60 days after getting over Covid, and no one like Moderna wants to give their full data, and my belief it’s the same otherwise from their phase one the first thing I’d be trumpeting is 30, 60, 90 days still robust antibody with cd4, cd8 long term memory tcell activation, but no one is saying that, and please with Oxford they are notorious exaggerators, it’s a really good business buying or giving someone 2-300 million, spend another 500 million to know what you know already, failure but your big time Lobbiest sin Washington plus your buddies give you a 1.6 billion dollar contract and make even with failure 100’s of millions, now that’s a great business, none of the partnerships would have ever of happened with big pharma if Covid did not take place and all the free cash, and all those great Lobbiest sin Washington that work for big pharma cause they pay millions a quarter, it’s really funny to me all the contracts went to companies with zero product but they got contracts only after they bought someone else’s product, hahaha do your DD.

Chuck Merchant and stop with the ridiculous comments, talk to me when I’m right in 3 mos.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 3

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
Havoc, CSBC Partner for Autonomous Maritime Future

Updated Category News Views 3

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 2

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 3

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 6

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 2

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 1

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Hedi Slimane's Departure from Celine: A Momentous Shift

Updated Category News Views 71

Hedi Slimane's Departure from Celine: What It Means Fashion designer Hedi Slimane has officially left LVMH's Celine brand, a transition that resonates deeply within the luxury fashion industry. This significant change comes at a time when several prominent designers have shifted their roles, hinting at broader industry turbulence. The New Leadership at Celine In the wake...

Continue Reading
First Capital, Inc. Shows Growth in Quarterly Earnings Report

Updated Category News Views 182

First Capital, Inc. Financial Performance Overview First Capital, Inc. (NASDAQ: FCAP), the entity behind First Harrison Bank, has showcased a strong financial performance in its most recent quarterly earnings report. The company reported a net income of $3.8 million or $1.13 per diluted share for the quarter ending June 30, contrasting sharply with $2.8 million or $0.85...

Continue Reading
Kala Bio Faces Major Setback as Research Hits Snag

Updated Category News Views 187

Understanding Kala Bio's Recent Stock Decline Kala Bio Inc. (NASDAQ: KALA) has experienced a significant drop in its stock price following an announcement about the halted development of an experimental treatment aimed at addressing a specific eye condition. The CHASE Trial Outcomes On a recent Monday, Kala Bio revealed that their CHASE Phase 2b clinical trial for...

Continue Reading
Iron Mountain to Highlight Innovations at Major Conference

Updated Category News Views 163

Iron Mountain Showcases Innovations at Major Conference Iron Mountain Incorporated (NYSE: IRM), recognized for its expertise in information management services, is preparing to make a notable impression at an upcoming financial conference. The company will take part in a fireside chat during the highly anticipated RBC Capital Markets Global Communications Infrastructure...

Continue Reading
Windstar Cruises Unveils Unique Dining on Star Seeker

Updated Category News Views 160

Windstar Cruises Introduces Dining Venues on Star Seeker Windstar Cruises is excited to share insights into the interior design of the dining and lounge spaces on its upcoming yacht, Star Seeker. This vessel is set to redefine cruise experiences with its innovative approach to dining and social interaction. Amphora Restaurant: A Culinary Delight At the forefront of Star...

Continue Reading